Tag archive for ‘Pharma acquisition news’
By businessnewstoday On Tuesday, March 2nd, 2021

Altaris Capital Partners to acquire Perrigo Rx business for $1.5bn

(adsbygoogle = window.adsbygoogle || []).push({}); Altaris Capital Partners has agreed to acquire the prescription pharma (Rx) business of Perrigo Company plc, an Ireland-based pharma company, for More...

By businessnewstoday On Friday, February 26th, 2021

Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities

Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450 million, in an all-share deal. The Swiss biopharma company will also make additional More...

By businessnewstoday On Thursday, February 25th, 2021

Merck to acquire US biotech company Pandion Therapeutics for $1.8bn

Merck has agreed to acquire Pandion Therapeutics, a Massachusetts-based clinical-stage biotech company, for about $1.85 billion in an all-cash deal. Pandion Therapeutics is engaged in developing therapeutics for More...

By businessnewstoday On Thursday, February 18th, 2021

Eurofins Scientific to acquire Beacon Discovery to expand drug discovery capabilities

Eurofins Scientific, a testing laboratories company based in Luxembourg, has agreed to acquire Beacon Discovery, a drug discovery and contract research organization (CRO), engaged in the research of G-Protein Coupled More...

By pharmanewsdaily On Wednesday, February 17th, 2021

Human tissue developer Humacyte to go public via $1.1bn merger with Alpha Healthcare

Humacyte, a clinical-stage biotech platform company, has agreed to merge with blank check company Alpha Healthcare Acquisition Corp. (AHAC), in a deal that values the combined firm at $1.1 billion. Based in Durham, More...

By pharmanewsdaily On Saturday, February 13th, 2021

Sandoz to acquire GSK’s cephalosporin antibiotics business in $500m worth deal

Sandoz, a division of Swiss pharma giant Novartis, has agreed to acquire GSK’s cephalosporin antibiotics business in a deal worth up to $500 million. The deal gives Sandoz global rights to the Zinnat, Zinacef, More...

By pharmanewsdaily On Wednesday, February 3rd, 2021

Jazz Pharmaceuticals to acquire Epidiolex developer GW Pharmaceuticals for $7.2bn

Irish biopharma company Jazz Pharmaceuticals has agreed to acquire British pharma company GW Pharmaceuticals in a cash-cum-stock deal worth $7.2 billion. Upon closing of the deal, the combined firm is expected to More...

By pharmanewsdaily On Monday, February 1st, 2021

Horizon Therapeutics to acquire Viela Bio for $3bn to grow rare disease portfolio

Horizon Therapeutics, an Irish biopharma company, has agreed to acquire Viela Bio, a US-based biotech company, for $53 per share in cash or about $3.05 billion in a move to significantly expand its development pipeline More...

By pharmanewsdaily On Wednesday, January 27th, 2021

Nordic Capital offers to acquire Advanz Pharma for $846m

Nordic Capital has made an offer to acquire Advanz Pharma, a UK-based specialty pharma company, for about $846 million in cash. Advanz Pharma is said to focus strategically on complex medicines in Europe. The company’s More...

By pharmanewsdaily On Saturday, January 16th, 2021

Thermo Fisher acquires Henogen viral vector manufacturing business in Belgium from Novasep

Thermo Fisher Scientific has completed the acquisition of Groupe Novasep’s acquisition of viral vector manufacturing business in Belgium – Henogen for nearly €725 million in cash. The divested viral vector More...